Roflumilast Cream Effective for AD in Phase 3 Studies ...Middle East

Medscape - News
Treatment with roflumilast cream 0.15% once daily improved mild to moderate AD in two phase 3 randomized clinical trials of children 6 years or older and adults. Medscape Medical News

Hence then, the article about roflumilast cream effective for ad in phase 3 studies was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Roflumilast Cream Effective for AD in Phase 3 Studies )

Apple Storegoogle play

Last updated :

Also on site :